Susquehanna International Group
LRMR icon

Susquehanna International Group’s Larimar Therapeutics LRMR Stock Holding History

Susquehanna International Group’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$741K Buy
164,600
+20,200
+14% +$80.7K ﹤0.01% 8667
2025
Q4 		$550K Sell
144,400
-80,400
-36% -$313K ﹤0.01% 8552
2025
Q3 		$726K Buy
224,800
+176,000
+361% +$660K ﹤0.01% 8109
2025
Q2 		$141K Buy
48,800
+7,100
+17% +$16.4K ﹤0.01% 11546
2025
Q1 		$89.7K Buy
41,700
+15,200
+57% +$48K ﹤0.01% 11604
2024
Q4 		$103K Sell
26,500
-32,700
-55% -$216K ﹤0.01% 11324
2024
Q3 		$388K Buy
59,200
+1,700
+3% +$13.7K ﹤0.01% 9059
2024
Q2 		$417K Sell
57,500
-45,600
-44% -$349K ﹤0.01% 8714
2024
Q1 		$783K Buy
103,100
+72,600
+238% +$566K ﹤0.01% 7457
2023
Q4 		$139K Buy
30,500
+6,200
+26% +$20.9K ﹤0.01% 11042
2023
Q3 		$96K Buy
+24,300
New +$91.9K ﹤0.01% 10950
2022
Q2 		– Sell
-10,800
Closed -$44K – 13505
2022
Q1 		$44K Buy
+10,800
New +$70.7K ﹤0.01% 12360
2018
Q3 		– Sell
-3,258
Closed -$400K – 9803
2018
Q2 		$400K Buy
3,258
+825
+34% +$70.1K ﹤0.01% 7248
2018
Q1 		$218K Buy
+2,433
New +$206K ﹤0.01% 8185
2017
Q1 		– Sell
-2,358
Closed -$90K – 9512
2016
Q4 		$90K Sell
2,358
-2,234
-49% -$90.6K ﹤0.01% 9128
2016
Q3 		$182K Sell
4,592
-4,875
-51% -$221K ﹤0.01% 7649
2016
Q2 		$680K Buy
9,467
+684
+8% +$54.1K ﹤0.01% 5584
2016
Q1 		$704K Buy
8,783
+2,216
+34% +$175K ﹤0.01% 5784
2015
Q4 		$496K Buy
+6,567
New +$1.05M ﹤0.01% 6782
2015
Q3 		– Sell
-2,725
Closed -$1.13M – 9917
2015
Q2 		$1.13M Buy
+2,725
New +$1.14M ﹤0.01% 5944

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Susquehanna International Group's LRMR Position: Q1 2026 in Review

Susquehanna International Group reduced its Larimar Therapeutics (LRMR) stake by 45% in Q1 2026, selling an estimated $451K and leaving 140,060 shares worth $630K. The position accounts for ﹤0.01% of the portfolio, ranked #9067.

Susquehanna International Group first reported a position in LRMR in Q1 2015 and has held it in 29 quarters since. The position peaked at $1.29M in Q3 2015. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Susquehanna International Group held 140,060 shares of Larimar Therapeutics worth $630K as of Q1 2026.
  • Susquehanna International Group sold 112,723 Larimar Therapeutics shares in Q1 2026, an estimated $451K.
  • Larimar Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9067 holding.
  • Susquehanna International Group first reported a position in Larimar Therapeutics in Q1 2015 and has held it in 29 quarters since.
  • Susquehanna International Group's Larimar Therapeutics position peaked at $1.29M in Q3 2015.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.